| Name | Title | Contact Details |
|---|
Human Care HC Sweden AB is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Guess & Co. Corporation revitalizes and serves rural communities and neighboring urban communities through technology, real estate, energy, and health care solutions, along with providing diversified solutions to meet the needs of our clients. We work with communities, small businesses, corporations, and governments looking to grow and expand leveraging our solutions. Guess & Co. believes in the power of Rural America and the potential for meaningful partnerships between rural and neighboring urban communities that benefit the United States of America. We are committed to using our resources to build bridges of cooperation and support between rural and neighboring urban communities that strengthen our country. Our objective is to positively impact 100 million lives by 2032 through access, empowerment, economic development, and support through the solutions that we provide to clients. We align ourselves with others who are just as passionate about making lives better through technology, real estate, energy, health care and diversified solutions as we are. From our headquarters in Overland Park, Kansas we deliver solutions to clients in rural and neighboring urban communities. While we are based in the Midwestern region of the United States, our strategic footprint includes over 20 states throughout the country setup to meet the needs of clients. Our core businesses are technology, real estate, energy, and health care solutions. We also serve clients through our diversified solutions which range from consulting to commercial funding.
Medical Management Strategies is a San Luis Obispo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hallmark Health System is a Melrose, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.